img

Global New Psychoactive Substance Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global New Psychoactive Substance Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal New Psychoactive Substance Market
Global New Psychoactive Substance market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, New Psychoactive Substance industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, New Psychoactive Substance key companies include Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences, AusCann, Cannabics Pharmaceuticals, Tilray, Cyrelian, Anandia Laboratories and InMed Pharmaceuticals, etc. Zynerba Pharmaceuticals, GW Pharmaceuticals, Teewinot Life Sciences are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of New Psychoactive Substance were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole New Psychoactive Substance market and estimated to attract more attentions from industry insiders and investors.
New Psychoactive Substance can be divided into Stimulants, Cannabinoids, Hallucinogens and Depressants, etc. Stimulants is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
New Psychoactive Substance is widely used in various fields, such as Cancer, Neuropathic Disorders, Spasticity and Others, etc. Cancer provides greatest supports to the New Psychoactive Substance industry development. In 2022, global % revenue of New Psychoactive Substance went into Cancer filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global New Psychoactive Substance market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global New Psychoactive Substance market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Zynerba Pharmaceuticals
GW Pharmaceuticals
Teewinot Life Sciences
AusCann
Cannabics Pharmaceuticals
Tilray
Cyrelian
Anandia Laboratories
InMed Pharmaceuticals
Renew Biopharma
Cronos Group
ICC International Cannabis
Biotii Technologies
Segment by Type
Stimulants
Cannabinoids
Hallucinogens
Depressants

Segment by Application


Cancer
Neuropathic Disorders
Spasticity
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, New Psychoactive Substance introduction, etc. New Psychoactive Substance Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of New Psychoactive Substance
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Psychoactive Substance Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Stimulants
1.2.3 Cannabinoids
1.2.4 Hallucinogens
1.2.5 Depressants
1.3 Market by Application
1.3.1 Global New Psychoactive Substance Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Cancer
1.3.3 Neuropathic Disorders
1.3.4 Spasticity
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Psychoactive Substance Market Perspective (2018-2033)
2.2 Global New Psychoactive Substance Growth Trends by Region
2.2.1 New Psychoactive Substance Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 New Psychoactive Substance Historic Market Size by Region (2018-2023)
2.2.3 New Psychoactive Substance Forecasted Market Size by Region (2024-2033)
2.3 New Psychoactive Substance Market Dynamics
2.3.1 New Psychoactive Substance Industry Trends
2.3.2 New Psychoactive Substance Market Drivers
2.3.3 New Psychoactive Substance Market Challenges
2.3.4 New Psychoactive Substance Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue New Psychoactive Substance by Players
3.1.1 Global New Psychoactive Substance Revenue by Players (2018-2023)
3.1.2 Global New Psychoactive Substance Revenue Market Share by Players (2018-2023)
3.2 Global New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of New Psychoactive Substance, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global New Psychoactive Substance Market Concentration Ratio
3.4.1 Global New Psychoactive Substance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Psychoactive Substance Revenue in 2022
3.5 Global Key Players of New Psychoactive Substance Head office and Area Served
3.6 Global Key Players of New Psychoactive Substance, Product and Application
3.7 Global Key Players of New Psychoactive Substance, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 New Psychoactive Substance Breakdown Data by Type
4.1 Global New Psychoactive Substance Historic Market Size by Type (2018-2023)
4.2 Global New Psychoactive Substance Forecasted Market Size by Type (2024-2033)
5 New Psychoactive Substance Breakdown Data by Application
5.1 Global New Psychoactive Substance Historic Market Size by Application (2018-2023)
5.2 Global New Psychoactive Substance Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America New Psychoactive Substance Market Size (2018-2033)
6.2 North America New Psychoactive Substance Market Size by Type
6.2.1 North America New Psychoactive Substance Market Size by Type (2018-2023)
6.2.2 North America New Psychoactive Substance Market Size by Type (2024-2033)
6.2.3 North America New Psychoactive Substance Market Share by Type (2018-2033)
6.3 North America New Psychoactive Substance Market Size by Application
6.3.1 North America New Psychoactive Substance Market Size by Application (2018-2023)
6.3.2 North America New Psychoactive Substance Market Size by Application (2024-2033)
6.3.3 North America New Psychoactive Substance Market Share by Application (2018-2033)
6.4 North America New Psychoactive Substance Market Size by Country
6.4.1 North America New Psychoactive Substance Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America New Psychoactive Substance Market Size by Country (2018-2023)
6.4.3 North America New Psychoactive Substance Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe New Psychoactive Substance Market Size (2018-2033)
7.2 Europe New Psychoactive Substance Market Size by Type
7.2.1 Europe New Psychoactive Substance Market Size by Type (2018-2023)
7.2.2 Europe New Psychoactive Substance Market Size by Type (2024-2033)
7.2.3 Europe New Psychoactive Substance Market Share by Type (2018-2033)
7.3 Europe New Psychoactive Substance Market Size by Application
7.3.1 Europe New Psychoactive Substance Market Size by Application (2018-2023)
7.3.2 Europe New Psychoactive Substance Market Size by Application (2024-2033)
7.3.3 Europe New Psychoactive Substance Market Share by Application (2018-2033)
7.4 Europe New Psychoactive Substance Market Size by Country
7.4.1 Europe New Psychoactive Substance Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe New Psychoactive Substance Market Size by Country (2018-2023)
7.4.3 Europe New Psychoactive Substance Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China New Psychoactive Substance Market Size (2018-2033)
8.2 China New Psychoactive Substance Market Size by Type
8.2.1 China New Psychoactive Substance Market Size by Type (2018-2023)
8.2.2 China New Psychoactive Substance Market Size by Type (2024-2033)
8.2.3 China New Psychoactive Substance Market Share by Type (2018-2033)
8.3 China New Psychoactive Substance Market Size by Application
8.3.1 China New Psychoactive Substance Market Size by Application (2018-2023)
8.3.2 China New Psychoactive Substance Market Size by Application (2024-2033)
8.3.3 China New Psychoactive Substance Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia New Psychoactive Substance Market Size (2018-2033)
9.2 Asia New Psychoactive Substance Market Size by Type
9.2.1 Asia New Psychoactive Substance Market Size by Type (2018-2023)
9.2.2 Asia New Psychoactive Substance Market Size by Type (2024-2033)
9.2.3 Asia New Psychoactive Substance Market Share by Type (2018-2033)
9.3 Asia New Psychoactive Substance Market Size by Application
9.3.1 Asia New Psychoactive Substance Market Size by Application (2018-2023)
9.3.2 Asia New Psychoactive Substance Market Size by Application (2024-2033)
9.3.3 Asia New Psychoactive Substance Market Share by Application (2018-2033)
9.4 Asia New Psychoactive Substance Market Size by Region
9.4.1 Asia New Psychoactive Substance Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia New Psychoactive Substance Market Size by Region (2018-2023)
9.4.3 Asia New Psychoactive Substance Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America New Psychoactive Substance Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Type
10.2.1 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America New Psychoactive Substance Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Application
10.3.1 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America New Psychoactive Substance Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Country
10.4.1 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Details
11.1.2 Zynerba Pharmaceuticals Business Overview
11.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Introduction
11.1.4 Zynerba Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023)
11.1.5 Zynerba Pharmaceuticals Recent Developments
11.2 GW Pharmaceuticals
11.2.1 GW Pharmaceuticals Company Details
11.2.2 GW Pharmaceuticals Business Overview
11.2.3 GW Pharmaceuticals New Psychoactive Substance Introduction
11.2.4 GW Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023)
11.2.5 GW Pharmaceuticals Recent Developments
11.3 Teewinot Life Sciences
11.3.1 Teewinot Life Sciences Company Details
11.3.2 Teewinot Life Sciences Business Overview
11.3.3 Teewinot Life Sciences New Psychoactive Substance Introduction
11.3.4 Teewinot Life Sciences Revenue in New Psychoactive Substance Business (2018-2023)
11.3.5 Teewinot Life Sciences Recent Developments
11.4 AusCann
11.4.1 AusCann Company Details
11.4.2 AusCann Business Overview
11.4.3 AusCann New Psychoactive Substance Introduction
11.4.4 AusCann Revenue in New Psychoactive Substance Business (2018-2023)
11.4.5 AusCann Recent Developments
11.5 Cannabics Pharmaceuticals
11.5.1 Cannabics Pharmaceuticals Company Details
11.5.2 Cannabics Pharmaceuticals Business Overview
11.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Introduction
11.5.4 Cannabics Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023)
11.5.5 Cannabics Pharmaceuticals Recent Developments
11.6 Tilray
11.6.1 Tilray Company Details
11.6.2 Tilray Business Overview
11.6.3 Tilray New Psychoactive Substance Introduction
11.6.4 Tilray Revenue in New Psychoactive Substance Business (2018-2023)
11.6.5 Tilray Recent Developments
11.7 Cyrelian
11.7.1 Cyrelian Company Details
11.7.2 Cyrelian Business Overview
11.7.3 Cyrelian New Psychoactive Substance Introduction
11.7.4 Cyrelian Revenue in New Psychoactive Substance Business (2018-2023)
11.7.5 Cyrelian Recent Developments
11.8 Anandia Laboratories
11.8.1 Anandia Laboratories Company Details
11.8.2 Anandia Laboratories Business Overview
11.8.3 Anandia Laboratories New Psychoactive Substance Introduction
11.8.4 Anandia Laboratories Revenue in New Psychoactive Substance Business (2018-2023)
11.8.5 Anandia Laboratories Recent Developments
11.9 InMed Pharmaceuticals
11.9.1 InMed Pharmaceuticals Company Details
11.9.2 InMed Pharmaceuticals Business Overview
11.9.3 InMed Pharmaceuticals New Psychoactive Substance Introduction
11.9.4 InMed Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023)
11.9.5 InMed Pharmaceuticals Recent Developments
11.10 Renew Biopharma
11.10.1 Renew Biopharma Company Details
11.10.2 Renew Biopharma Business Overview
11.10.3 Renew Biopharma New Psychoactive Substance Introduction
11.10.4 Renew Biopharma Revenue in New Psychoactive Substance Business (2018-2023)
11.10.5 Renew Biopharma Recent Developments
11.11 Cronos Group
11.11.1 Cronos Group Company Details
11.11.2 Cronos Group Business Overview
11.11.3 Cronos Group New Psychoactive Substance Introduction
11.11.4 Cronos Group Revenue in New Psychoactive Substance Business (2018-2023)
11.11.5 Cronos Group Recent Developments
11.12 ICC International Cannabis
11.12.1 ICC International Cannabis Company Details
11.12.2 ICC International Cannabis Business Overview
11.12.3 ICC International Cannabis New Psychoactive Substance Introduction
11.12.4 ICC International Cannabis Revenue in New Psychoactive Substance Business (2018-2023)
11.12.5 ICC International Cannabis Recent Developments
11.13 Biotii Technologies
11.13.1 Biotii Technologies Company Details
11.13.2 Biotii Technologies Business Overview
11.13.3 Biotii Technologies New Psychoactive Substance Introduction
11.13.4 Biotii Technologies Revenue in New Psychoactive Substance Business (2018-2023)
11.13.5 Biotii Technologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global New Psychoactive Substance Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Stimulants
Table 3. Key Players of Cannabinoids
Table 4. Key Players of Hallucinogens
Table 5. Key Players of Depressants
Table 6. Global New Psychoactive Substance Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global New Psychoactive Substance Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global New Psychoactive Substance Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global New Psychoactive Substance Market Share by Region (2018-2023)
Table 10. Global New Psychoactive Substance Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global New Psychoactive Substance Market Share by Region (2024-2033)
Table 12. New Psychoactive Substance Market Trends
Table 13. New Psychoactive Substance Market Drivers
Table 14. New Psychoactive Substance Market Challenges
Table 15. New Psychoactive Substance Market Restraints
Table 16. Global New Psychoactive Substance Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global New Psychoactive Substance Revenue Share by Players (2018-2023)
Table 18. Global Top New Psychoactive Substance by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2022)
Table 19. Global New Psychoactive Substance Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by New Psychoactive Substance Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of New Psychoactive Substance, Headquarters and Area Served
Table 22. Global Key Players of New Psychoactive Substance, Product and Application
Table 23. Global Key Players of New Psychoactive Substance, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global New Psychoactive Substance Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global New Psychoactive Substance Revenue Market Share by Type (2018-2023)
Table 27. Global New Psychoactive Substance Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global New Psychoactive Substance Revenue Market Share by Type (2024-2033)
Table 29. Global New Psychoactive Substance Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global New Psychoactive Substance Revenue Share by Application (2018-2023)
Table 31. Global New Psychoactive Substance Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global New Psychoactive Substance Revenue Share by Application (2024-2033)
Table 33. North America New Psychoactive Substance Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America New Psychoactive Substance Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America New Psychoactive Substance Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America New Psychoactive Substance Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America New Psychoactive Substance Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe New Psychoactive Substance Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe New Psychoactive Substance Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe New Psychoactive Substance Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe New Psychoactive Substance Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe New Psychoactive Substance Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 47. China New Psychoactive Substance Market Size by Type (2018-2023) & (US$ Million)
Table 48. China New Psychoactive Substance Market Size by Type (2024-2033) & (US$ Million)
Table 49. China New Psychoactive Substance Market Size by Application (2018-2023) & (US$ Million)
Table 50. China New Psychoactive Substance Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia New Psychoactive Substance Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia New Psychoactive Substance Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia New Psychoactive Substance Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia New Psychoactive Substance Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia New Psychoactive Substance Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia New Psychoactive Substance Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia New Psychoactive Substance Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America New Psychoactive Substance Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 65. Zynerba Pharmaceuticals Company Details
Table 66. Zynerba Pharmaceuticals Business Overview
Table 67. Zynerba Pharmaceuticals New Psychoactive Substance Product
Table 68. Zynerba Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 69. Zynerba Pharmaceuticals Recent Developments
Table 70. GW Pharmaceuticals Company Details
Table 71. GW Pharmaceuticals Business Overview
Table 72. GW Pharmaceuticals New Psychoactive Substance Product
Table 73. GW Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 74. GW Pharmaceuticals Recent Developments
Table 75. Teewinot Life Sciences Company Details
Table 76. Teewinot Life Sciences Business Overview
Table 77. Teewinot Life Sciences New Psychoactive Substance Product
Table 78. Teewinot Life Sciences Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 79. Teewinot Life Sciences Recent Developments
Table 80. AusCann Company Details
Table 81. AusCann Business Overview
Table 82. AusCann New Psychoactive Substance Product
Table 83. AusCann Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 84. AusCann Recent Developments
Table 85. Cannabics Pharmaceuticals Company Details
Table 86. Cannabics Pharmaceuticals Business Overview
Table 87. Cannabics Pharmaceuticals New Psychoactive Substance Product
Table 88. Cannabics Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 89. Cannabics Pharmaceuticals Recent Developments
Table 90. Tilray Company Details
Table 91. Tilray Business Overview
Table 92. Tilray New Psychoactive Substance Product
Table 93. Tilray Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 94. Tilray Recent Developments
Table 95. Cyrelian Company Details
Table 96. Cyrelian Business Overview
Table 97. Cyrelian New Psychoactive Substance Product
Table 98. Cyrelian Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 99. Cyrelian Recent Developments
Table 100. Anandia Laboratories Company Details
Table 101. Anandia Laboratories Business Overview
Table 102. Anandia Laboratories New Psychoactive Substance Product
Table 103. Anandia Laboratories Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 104. Anandia Laboratories Recent Developments
Table 105. InMed Pharmaceuticals Company Details
Table 106. InMed Pharmaceuticals Business Overview
Table 107. InMed Pharmaceuticals New Psychoactive Substance Product
Table 108. InMed Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 109. InMed Pharmaceuticals Recent Developments
Table 110. Renew Biopharma Company Details
Table 111. Renew Biopharma Business Overview
Table 112. Renew Biopharma New Psychoactive Substance Product
Table 113. Renew Biopharma Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 114. Renew Biopharma Recent Developments
Table 115. Cronos Group Company Details
Table 116. Cronos Group Business Overview
Table 117. Cronos Group New Psychoactive Substance Product
Table 118. Cronos Group Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 119. Cronos Group Recent Developments
Table 120. ICC International Cannabis Company Details
Table 121. ICC International Cannabis Business Overview
Table 122. ICC International Cannabis New Psychoactive Substance Product
Table 123. ICC International Cannabis Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 124. ICC International Cannabis Recent Developments
Table 125. Biotii Technologies Company Details
Table 126. Biotii Technologies Business Overview
Table 127. Biotii Technologies New Psychoactive Substance Product
Table 128. Biotii Technologies Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 129. Biotii Technologies Recent Developments
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global New Psychoactive Substance Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global New Psychoactive Substance Market Share by Type: 2022 VS 2033
Figure 3. Stimulants Features
Figure 4. Cannabinoids Features
Figure 5. Hallucinogens Features
Figure 6. Depressants Features
Figure 7. Global New Psychoactive Substance Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global New Psychoactive Substance Market Share by Application: 2022 VS 2033
Figure 9. Cancer Case Studies
Figure 10. Neuropathic Disorders Case Studies
Figure 11. Spasticity Case Studies
Figure 12. Others Case Studies
Figure 13. New Psychoactive Substance Report Years Considered
Figure 14. Global New Psychoactive Substance Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global New Psychoactive Substance Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global New Psychoactive Substance Market Share by Region: 2022 VS 2033
Figure 17. Global New Psychoactive Substance Market Share by Players in 2022
Figure 18. Global Top New Psychoactive Substance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by New Psychoactive Substance Revenue in 2022
Figure 20. North America New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America New Psychoactive Substance Market Share by Type (2018-2033)
Figure 22. North America New Psychoactive Substance Market Share by Application (2018-2033)
Figure 23. North America New Psychoactive Substance Market Share by Country (2018-2033)
Figure 24. United States New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe New Psychoactive Substance Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe New Psychoactive Substance Market Share by Type (2018-2033)
Figure 28. Europe New Psychoactive Substance Market Share by Application (2018-2033)
Figure 29. Europe New Psychoactive Substance Market Share by Country (2018-2033)
Figure 30. Germany New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China New Psychoactive Substance Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China New Psychoactive Substance Market Share by Type (2018-2033)
Figure 38. China New Psychoactive Substance Market Share by Application (2018-2033)
Figure 39. Asia New Psychoactive Substance Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia New Psychoactive Substance Market Share by Type (2018-2033)
Figure 41. Asia New Psychoactive Substance Market Share by Application (2018-2033)
Figure 42. Asia New Psychoactive Substance Market Share by Region (2018-2033)
Figure 43. Japan New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America New Psychoactive Substance Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America New Psychoactive Substance Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America New Psychoactive Substance Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America New Psychoactive Substance Market Share by Country (2018-2033)
Figure 53. Brazil New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Zynerba Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 60. GW Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 61. Teewinot Life Sciences Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 62. AusCann Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 63. Cannabics Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 64. Tilray Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 65. Cyrelian Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 66. Anandia Laboratories Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 67. InMed Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 68. Renew Biopharma Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 69. Cronos Group Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 70. ICC International Cannabis Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 71. Biotii Technologies Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries